ABBV-105, a selective and irreversible inhibitor of Bruton's tyrosine kinase, is efficacious in multiple preclinical models of inflammation (vol 29 , pg 510, 2018) Christian Goessa,Christopher M. Harris,Sara Murdock, Richard W. McCarthy,Erik Sampson, Rachel Twomey,Suzanne Mathieu, Regina Mario, Matthew Perham,Eric R. Goedken,Andrew J. LongMODERN RHEUMATOLOGY（2019）引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
